Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Suspended 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Dermatologic 2Genitourinary 1

Conditions

Leukemia, Myeloid, Acute 3Prostatic Neoplasms 2Pancreatic Neoplasms 2Neoplasms 2Melanoma 2Malignant Solid Neoplasm 2Hematopoietic and Lymphatic System Neoplasm 2Hematologic Neoplasms 2Colorectal Neoplasms 2Carcinoma, Renal Cell 2COVID-19 2Urologic Neoplasms 1Urologic Diseases 1Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Teratoma 1Stomatitis 1Squamous Cell Carcinoma of Head and Neck 1Spondylitis, Ankylosing 1Renal Insufficiency, Chronic 1Psoriasis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Peritoneal Neoplasms 1Oropharyngeal Neoplasms 1Neoplasms, Germ Cell and Embryonal 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Mouth Neoplasms 1

Interventions

pembrolizumab 19Nivolumab 18Specimen Handling 16Magnetic Resonance Spectroscopy 12Ipilimumab 11Biopsy 6relatlimab 4Opdualag 4CTLA-4 Antigen 4trametinib 3dabrafenib 3binimetinib 3aldesleukin 3Cyclophosphamide 3omipalisib 2fludarabine 2capivasertib 2atezolizumab 2X-Rays 2Taxes 2Surveys and Questionnaires 2Standard of Care 2Radiosurgery 2Radiation 2Practice Guidelines as Topic 2Pemetrexed 2Paclitaxel 2Methods 2Introns 2Interferon alpha-2 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Melanoma × Practice Guidelines as Topic × 30 days × Clear all
NCT06391099 2026-05-26

Ketogenic Dietary Intervention to Improve Response to Immunotherapy in Patients With Metastatic Melanoma and Metastatic Kidney Cancer

Ohio State University Comprehensive Cancer Center

Phase NA Suspended
60 enrolled
DermatologicGenitourinary

Carcinoma, Renal Cell, Melanoma

NCT04751396 2026-05-20

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

M.D. Anderson Cancer Center

Recruiting
125 enrolled
Dermatologic

Arthritis, Rheumatoid, Autoimmune Diseases, Colitis, Ulcerative, Crohn Disease, Lupus Erythematosus, Systemic, Melanoma, Psoriasis, Spondylitis, Ankylosing, Inflammatory Bowel Diseases, Arthritis, Psoriatic, Arthritis, Reactive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡